Elenco degli articoli con argomento «secukinumab»
Dermatologia14 mar 2022
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients
Secukinumab effectiveness has been demonstrated in both psoriasis (PsO) and psoriatic arthritis (PsA)
15 giu 2020
Treatment of erythrodermic psoriasis with biologics
A systematic review
03 giu 2019
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate to severe plaque-type psoriasis
Recent studies have shown that biological drugs approved for treating psoriasis and psoriatic arthritis are not effective in all patients, and that variations in the genome have been associated with different clinical responses or side effects.
14 mag 2019
Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis
Secukinumab is administered at the labelled dose of 300 mg at weeks 0, 1, 2, 3, 4 (loading dose) and every 4 weeks thereafter